Although the relationship between SLC16A3 and cholestasis pathogenesis is unclear, recent research has identified this gene as a potential prognostic biomarker related to intrahepatic cholangiocarcinoma cell reprogramming (Dong et al. 2022). The gene discussed is SLC16A3; the disease is cholestasis.